thyroid cancer

(ECCO-the European CanCer Organisation) Preliminary trials of a new multi-kinase inhibitor have indicated it has impressive tumor shrinkage activity in patients with a difficult to treat type of thyroid cancer.

The results have put the drug's development on a fast track, prompting the accelerated initiation of a large phase III trial.

(American Cancer Society) The American Cancer Society, the nation's largest voluntary health organization, has received a gift of $8.5 million from a single anonymous donor.

The contribution, one of the largest individual scientific research gifts in the Society's 95-year history, will be earmarked for targeted investigation into a genetic disorder that leads to a high lifetime risk of several types of cancer, most often thyroid cancer.